Physician profile
Jane Lisko
NPI 1619910890
$9,516.35
in general payments reported to CMS, 2019-2025
21 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $33.32 · 2021: $4,346 · 2022: $4,245 · 2023: $164 · 2024: $173 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $8,627.80 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $141.45 | 2019-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $114.84 | 2019-2025 | |
| Incyte Corporation | $80.44 | 2022-2024 | Opzelura |
| Mimedx Group, INC. | $77.30 | 2025 | |
| Biofrontera INC. | $71.07 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Lilly USA, LLC | $68.76 | 2021-2024 | Taltz, Ebglyss |
| Novartis Pharmaceuticals Corporation | $44.39 | 2022-2025 | |
| Janssen Biotech, INC. | $44.13 | 2022-2023 | Simponi, Remicade, Simponi Aria |
| Leo Pharma INC. | $44.11 | 2023-2024 | Adbry |
| Celgene Corporation | $38.11 | 2019 | |
| Surgenex LLC | $34.73 | 2025 | Renograft, Surgraft, Ardeograft |
| Amgen INC. | $33.32 | 2020 | |
| Dusa Pharmaceuticals, INC. | $16.10 | 2019 | |
| Arcutis Biotherapeutics, INC. | $13.82 | 2024 | Zoryve |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $13.14 | 2019 | |
| Pfizer INC. | $12.84 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.70 | 2023 | Sotyktu |
| Dermira, INC. | $11.54 | 2019 | |
| Galderma Laboratories, L.P. | $11.07 | 2019 | |
| Organon LLC | $4.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Lisko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.